Parsons Analyst Price Targets - Benzinga

Parsons Corp

PSNNYSE

Trade with Public

Trade with Public

$41.34

-0.21-0.51%

Ult. Agg.: Sep 30, 2:58 PM

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

Parsons Analyst Price Targets

Wall Street analyst price targets and consensus rating for Parsons (PSN).

Price Target Range — 12 Quarters

Analyst Consensus — 13 Analysts

1S.Buy

10Buy

2Hold

Consensus RatingBuy# Analysts13Avg. Consensus PT$73Upside to Avg. PT+77.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 21, 2026	Baird	Andrew Wittmann	Upgrade	Neutral→Outperform	$48→$57
Aug 3, 2026	Goldman Sachs	Noah Poponak	PT Cut	Neutral	$69→$60
Jul 30, 2026	UBS	Gavin Parsons	PT Cut	Buy	$67→$58
Jul 30, 2026	Citigroup	John Godyn	PT Cut	Buy	$66→$53
Jul 30, 2026	Stifel	Jonathan Siegmann	PT Cut	Buy	$79→$66
Jul 30, 2026	Truist Securities	Tobey Sommer	PT Cut	Buy	$75→$60
Jul 30, 2026	Barclays	Adam Seiden	PT Cut	Overweight	$70→$60
Jul 1, 2026	Citigroup	John Godyn	PT Raise	Buy	$65→$66
Apr 30, 2026	Citigroup	John Godyn	PT Cut	Buy	$70→$65
Apr 20, 2026	Truist Securities	Tobey Sommer	PT Cut	Buy	$85→$75
Apr 15, 2026	Keybanc	Sangita Jain	Downgrade	Overweight→Sector Weight	—
Apr 13, 2026	Baird	Andrew Wittmann	Downgrade	Outperform→Neutral	$60
Apr 2, 2026	Citigroup	John Godyn	PT Cut	Buy	$88→$70
Mar 31, 2026	Barclays	Adam Seiden	PT Cut	Overweight	$78→$70
Feb 12, 2026	UBS	Gavin Parsons	PT Cut	Buy	$104→$95
Feb 12, 2026	Keybanc	Sangita Jain	PT Cut	Overweight	$80→$73
Feb 12, 2026	Truist Securities	Tobey Sommer	PT Cut	Buy	$90→$85
Jan 23, 2026	Barclays	Adam Seiden	PT Raise	Overweight	$70→$78
Jan 20, 2026	Keybanc	Sangita Jain	PT Raise	Overweight	$76→$80
Jan 15, 2026	UBS	Gavin Parsons	PT Cut	Buy	$107→$104

More with Benzinga EdgeGet Access

Analyst Ratings News

This Equifax Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Wall Street analysts upgraded Parsons Corp, InnovAge Holding Corp, Equifax Inc, and initiated coverage on Builders FirstSource, Inc and Nuvation Bio Inc.

Avi Kapoor

PRO
Baird Upgrades Parsons to Outperform, Raises Price Target to $57

Baird analyst Andrew Wittmann upgrades Parsons (NYSE:PSN) from Neutral to Outperform and raises the price target from $48 to $57.

Benzinga Newsdesk

PRO
Goldman Sachs Maintains Neutral on Parsons, Lowers Price Target to $60

Goldman Sachs analyst Noah Poponak maintains Parsons (NYSE:PSN) with a Neutral and lowers the price target from $69 to $60.

Benzinga Newsdesk

Parsons Faces Earnings Pressure After Reducing 2026 Revenue Outlook

Parsons shares declined after the company reported mixed Q2 results, reduced FY2026 guidance, and faced pressure from portfolio restructuring actions.

Lekha Gupta

PRO
UBS Maintains Buy on Parsons, Lowers Price Target to $58

UBS analyst Gavin Parsons maintains Parsons (NYSE:PSN) with a Buy and lowers the price target from $67 to $58.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Parsons, Lowers Price Target to $53

Citigroup analyst John Godyn maintains Parsons (NYSE:PSN) with a Buy and lowers the price target from $66 to $53.

Benzinga Newsdesk